Human Leukocyte Antigens (HLA) Genes Association in Type 1 Diabetic Nephropathy

Endocr Metab Immune Disord Drug Targets. 2019;19(8):1157-1164. doi: 10.2174/1871530319666190215143059.

Abstract

Background: Diabetic nephropathy is a common worldwide multifactorial disease where involvement of genetic factors is well etablished. The aim of this study was to investigate the HLA genes implication in the development of type 1 diabetic nephropathy.

Methods: We performed a case- control study where one hundred and fifty subjects were examined. Patients were divided in two groups; with and without type 1 diabetic nephropathy. HLA typing was performed using Polymerase Chain Reaction- Sequence Specific Oligonucleotide (PCR- SSO) method. HLA association to clinical phenotype and HLA haplotype analysis was also investigated.

Results: HLA B*51 is increased in patients without type 1 diabetic nephropathy (7.14% vs. 0 %, P <0.05, OR= 0), however no other studied alleles seem to have any effect (all P>0.05). Haplotype analysis also does not reveal any significant association, however, A*02-B*18-DRB1*03-DQA1*05- DQB1*03 haplotype shows a tendency to be associated with the development of diabetic nephropathy (P = 0.05).

Conclusion: These results suggest a protective effect of HLA B*51 allele from type 1 diabetic nephropathy. However, further studies are required in order to clarify its potential implication as a protective marker.

Keywords: Type 1diabetes; alleles; analysis; class I HLA genes; class II HLA genes; diabetic nephropathy; haplotype analysis..

MeSH terms

  • Adult
  • Case-Control Studies
  • Diabetes Mellitus, Type 1 / diagnosis
  • Diabetes Mellitus, Type 1 / genetics*
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetic Nephropathies / diagnosis
  • Diabetic Nephropathies / genetics*
  • Diabetic Nephropathies / immunology
  • Female
  • Gene Frequency
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • HLA Antigens / genetics*
  • HLA Antigens / immunology
  • Haplotypes
  • Humans
  • Male
  • Middle Aged
  • Protective Factors
  • Risk Assessment
  • Risk Factors
  • Young Adult

Substances

  • HLA Antigens